{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:44:11Z","timestamp":1794980651577,"version":"4.9.1"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"crossref","award":["104004092 and 104004460"],"award-info":[{"award-number":["104004092 and 104004460"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wong's donation","award":["200006276"],"award-info":[{"award-number":["200006276"]}]},{"name":"Gaia Family Trust of New Zealand","award":["200007008"],"award-info":[{"award-number":["200007008"]}]},{"name":"Research Grants Committee (RGC) of Hong Kong, HKSAR","award":["740608, 766211, 17152116 and 17121419"],"award-info":[{"award-number":["740608, 766211, 17152116 and 17121419"]}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"crossref","award":["15162961, 16172751, 18192141 and 21222101"],"award-info":[{"award-number":["15162961, 16172751, 18192141 and 21222101"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Enhanced new staff start-up fund","award":["204610519"],"award-info":[{"award-number":["204610519"]}]},{"name":"Pre-emptive retention fund","award":["202007002"],"award-info":[{"award-number":["202007002"]}]},{"name":"The Hubei Provincial International Science and Technology Cooperation Program","award":["2022EHB046"],"award-info":[{"award-number":["2022EHB046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02379-7","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:32:27Z","timestamp":1752467547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development"],"prefix":"10.1186","volume":"24","author":[{"given":"Guoming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"2379_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B. L\u00f3pez-Soriano, F.J. Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer. 2014;14:754\u201362.","journal-title":"Nat Rev Cancer"},{"key":"2379_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argil\u00e9s","year":"2023","unstructured":"Argil\u00e9s JM, L\u00f3pez-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20:250\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"2379_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan T, et al. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol. 2023;16:54.","journal-title":"J Hematol Oncol"},{"key":"2379_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","volume":"4","author":"SF Schmidt","year":"2018","unstructured":"Schmidt SF, Rohm M, Herzig S, Berriel DM. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer. 2018;4:849\u201360.","journal-title":"Trends Cancer"},{"key":"2379_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","volume":"186","author":"M Ferrer","year":"2023","unstructured":"Ferrer M, et al. Cachexia: A systemic consequence of progressive, unresolved disease. Cell. 2023;186:1824\u201345.","journal-title":"Cell"},{"key":"2379_CR6","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jcsm.13216","volume":"14","author":"T Shukuya","year":"2023","unstructured":"Shukuya T, et al. Epidemiology, risk factors and impact of cachexia on patient outcome: results from the Japanese lung Cancer registry study. J Cachexia Sarcopenia Muscle. 2023;14:1274\u201385.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR7","first-page":"1871","volume":"26","author":"OM Vagnildhaug","year":"2018","unstructured":"Vagnildhaug OM, et al. A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer. Support Care Cancer. 2018;26:1871\u201380.","journal-title":"Support Care Cancer"},{"key":"2379_CR8","doi-asserted-by":"crossref","unstructured":"Kasprzak A. The role of tumor microenvironment cells in colorectal Cancer (CRC) Cachexia. Int J Mol Sci 22 (2021).","DOI":"10.3390\/ijms22041565"},{"key":"2379_CR9","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"key":"2379_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o M, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11:933\u201359.","journal-title":"Cancer Discov"},{"key":"2379_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","volume":"65","author":"C Belli","year":"2018","unstructured":"Belli C, et al. Targeting the microenvironment in solid tumors. Cancer Treat Rev. 2018;65:22\u201332.","journal-title":"Cancer Treat Rev"},{"key":"2379_CR12","doi-asserted-by":"publisher","first-page":"114444","DOI":"10.1016\/j.addr.2022.114444","volume":"188","author":"S Li","year":"2022","unstructured":"Li S, et al. Advances of bacteria-based delivery systems for modulating tumor microenvironment. Adv Drug Deliv Rev. 2022;188:114444.","journal-title":"Adv Drug Deliv Rev"},{"key":"2379_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5:166.","journal-title":"Signal Transduct Target Ther"},{"key":"2379_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-018-0800-6","volume":"17","author":"HY Tan","year":"2018","unstructured":"Tan HY, et al. Targeting tumour microenvironment by tyrosine kinase inhibitor. Mol Cancer. 2018;17:43.","journal-title":"Mol Cancer"},{"key":"2379_CR15","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13:6619.","journal-title":"Nat Commun"},{"key":"2379_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, et al. A framework for advancing our Understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"2379_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.ccell.2022.09.015","volume":"40","author":"DS Foster","year":"2022","unstructured":"Foster DS, et al. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022;40:1392\u2013e14067.","journal-title":"Cancer Cell"},{"key":"2379_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N. Scherz-Shouval, R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3:793\u2013807.","journal-title":"Nat Cancer"},{"key":"2379_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"2379_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"2379_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","volume":"22","author":"H Baazim","year":"2022","unstructured":"Baazim H, Antonio-Herrera L, Bergthaler A. The interplay of immunology and cachexia in infection and cancer. Nat Rev Immunol. 2022;22:309\u201321.","journal-title":"Nat Rev Immunol"},{"key":"2379_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s12276-022-00752-w","volume":"54","author":"E Yeom","year":"2022","unstructured":"Yeom E, Yu K. Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia. Exp Mol Med. 2022;54:426\u201332.","journal-title":"Exp Mol Med"},{"key":"2379_CR23","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","volume":"6","author":"J Arends","year":"2021","unstructured":"Arends J, et al. Cancer cachexia in adult patients: ESMO clinical practice Guidelines(\u2606). ESMO Open. 2021;6:100092.","journal-title":"ESMO Open"},{"key":"2379_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1\u20139.","journal-title":"Clin Nutr"},{"key":"2379_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10:90\u20139.","journal-title":"Nat Rev Clin Oncol"},{"key":"2379_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519\u201331.","journal-title":"Lancet Oncol"},{"key":"2379_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","volume":"8","author":"EE Talbert","year":"2022","unstructured":"Talbert EE, Guttridge DC. Emerging signaling mediators in the anorexia-cachexia syndrome of cancer. Trends Cancer. 2022;8:397\u2013403.","journal-title":"Trends Cancer"},{"key":"2379_CR28","doi-asserted-by":"crossref","unstructured":"Nishikawa H et al. Cancer cachexia: its mechanism and clinical significance. Int J Mol Sci 22 (2021).","DOI":"10.3390\/ijms22168491"},{"key":"2379_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"2379_CR30","doi-asserted-by":"publisher","first-page":"104378","DOI":"10.1016\/j.critrevonc.2024.104378","volume":"199","author":"JJ Thompson","year":"2024","unstructured":"Thompson JJ, et al. The relationship between LDH and GLIM criteria for cancer cachexia: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2024;199:104378.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2379_CR31","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.trecan.2022.07.005","volume":"8","author":"DV Runco","year":"2022","unstructured":"Runco DV, Zimmers TA, Bonetto A. The urgent need to improve childhood cancer cachexia. Trends Cancer. 2022;8:976\u20139.","journal-title":"Trends Cancer"},{"key":"2379_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12929-021-00714-w","volume":"28","author":"T Ollewagen","year":"2021","unstructured":"Ollewagen T, Myburgh KH, van de Vyver M, Smith C. Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche. J Biomed Sci. 2021;28:15.","journal-title":"J Biomed Sci"},{"key":"2379_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.semcancer.2016.01.002","volume":"36","author":"A Sukari","year":"2016","unstructured":"Sukari A, Muqbil I, Mohammad RM, Philip PA, Azmi AS. F-BOX proteins in cancer cachexia and muscle wasting: emerging regulators and therapeutic opportunities. Semin Cancer Biol. 2016;36:95\u2013104.","journal-title":"Semin Cancer Biol"},{"key":"2379_CR34","first-page":"4009","volume":"291","author":"S Agca","year":"2024","unstructured":"Agca S, Kir S. The role of interleukin-6 family cytokines in cancer cachexia. FEBS J. 2024;291:4009\u201323.","journal-title":"FEBS J"},{"key":"2379_CR35","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1038\/s42255-024-01167-9","volume":"6","author":"DM Berriel","year":"2024","unstructured":"Berriel DM, Rohm M, Herzig S. Cancer cachexia: multilevel metabolic dysfunction. Nat Metab. 2024;6:2222\u201345.","journal-title":"Nat Metab"},{"key":"2379_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/bjc.2016.3","volume":"114","author":"CA Penafuerte","year":"2016","unstructured":"Penafuerte CA, et al. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br J Cancer. 2016;114:680\u20137.","journal-title":"Br J Cancer"},{"key":"2379_CR37","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/jcsm.13246","volume":"14","author":"A Dolly","year":"2023","unstructured":"Dolly A, et al. Impairment of Aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia. J Cachexia Sarcopenia Muscle. 2023;14:1569\u201382.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee EG, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289:2350\u20134.","journal-title":"Science"},{"key":"2379_CR39","doi-asserted-by":"crossref","unstructured":"Callaway CS et al. IL-8 released from human pancreatic Cancer and Tumor-Associated stromal cells signals through a CXCR2-ERK1\/2 Axis to induce muscle atrophy. Cancers (Basel) 11 (2019).","DOI":"10.3390\/cancers11121863"},{"key":"2379_CR40","doi-asserted-by":"crossref","unstructured":"Penna F, Rubini G, Costelli P, Immunomodulation. A new approach to cancer cachexia, potentially suitable for aging. Mol Aspects Med. 2024;100:101318.","DOI":"10.1016\/j.mam.2024.101318"},{"key":"2379_CR41","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/s41467-023-37595-6","volume":"14","author":"M Beltr\u00e0","year":"2023","unstructured":"Beltr\u00e0 M, et al. NAD(+) repletion with niacin counteracts cancer cachexia. Nat Commun. 2023;14:1849.","journal-title":"Nat Commun"},{"key":"2379_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41421-022-00466-3","volume":"8","author":"J Han","year":"2022","unstructured":"Han J, et al. Single-cell sequencing unveils key contributions of immune cell populations in cancer-associated adipose wasting. Cell Discov. 2022;8:122.","journal-title":"Cell Discov"},{"key":"2379_CR43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu M, et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell. 2024;42:885\u2013e9034.","journal-title":"Cancer Cell"},{"key":"2379_CR44","doi-asserted-by":"crossref","unstructured":"Petruzzelli M et al. Early neutrophilia marked by aerobic Glycolysis sustains host metabolism and delays Cancer cachexia. Cancers (Basel) 14 (2022).","DOI":"10.3390\/cancers14040963"},{"key":"2379_CR45","doi-asserted-by":"crossref","unstructured":"Burfeind KG et al. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. Elife 9 (2020).","DOI":"10.7554\/eLife.54095"},{"key":"2379_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang D, et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J Hematol Oncol. 2023;16:30.","journal-title":"J Hematol Oncol"},{"key":"2379_CR47","doi-asserted-by":"publisher","first-page":"C661","DOI":"10.1152\/ajpcell.00327.2024","volume":"327","author":"BN VanderVeen","year":"2024","unstructured":"VanderVeen BN, et al. Involvement of the gut microbiota in cancer cachexia. Am J Physiol Cell Physiol. 2024;327:C661\u201370.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2379_CR48","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/s41396-021-00998-8","volume":"15","author":"Y Ni","year":"2021","unstructured":"Ni Y, et al. Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients. ISME J. 2021;15:3207\u201320.","journal-title":"ISME J"},{"key":"2379_CR49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12967-024-05201-y","volume":"22","author":"Q Ru","year":"2024","unstructured":"Ru Q, Chen L, Xu G, Wu Y. Exosomes in the pathogenesis and treatment of cancer-related cachexia. J Transl Med. 2024;22:408.","journal-title":"J Transl Med"},{"key":"2379_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12967-024-05266-9","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ding S. Extracellular vesicles in cancer cachexia: Deciphering pathogenic roles and exploring therapeutic horizons. J Transl Med. 2024;22:506.","journal-title":"J Transl Med"},{"key":"2379_CR51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrclinonc.2015.200","volume":"13","author":"P Anandavadivelan","year":"2016","unstructured":"Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13:185\u201398.","journal-title":"Nat Rev Clin Oncol"},{"key":"2379_CR52","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1172\/JCI128411","volume":"130","author":"I Boehm","year":"2020","unstructured":"Boehm I, et al. Neuromuscular junctions are stable in patients with cancer cachexia. J Clin Invest. 2020;130:1461\u20135.","journal-title":"J Clin Invest"},{"key":"2379_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli M, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014;20:433\u201347.","journal-title":"Cell Metab"},{"key":"2379_CR54","doi-asserted-by":"publisher","first-page":"188359","DOI":"10.1016\/j.bbcan.2020.188359","volume":"1873","author":"JA Siddiqui","year":"2020","unstructured":"Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: intersection between affected organs, mediators, and Pharmacological interventions. Biochim Biophys Acta Rev Cancer. 2020;1873:188359.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2379_CR55","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tem.2021.03.007","volume":"32","author":"T Siff","year":"2021","unstructured":"Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-Mediated muscle cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32:382\u2013402.","journal-title":"Trends Endocrinol Metab"},{"key":"2379_CR56","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcsm.12633","volume":"11","author":"A Dolly","year":"2020","unstructured":"Dolly A, Dumas JF, Servais S. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know? J Cachexia Sarcopenia Muscle. 2020;11:1413\u201328.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR57","doi-asserted-by":"publisher","first-page":"1289537","DOI":"10.3389\/fphys.2023.1289537","volume":"14","author":"X Pang","year":"2023","unstructured":"Pang X, Zhang P, Chen X, Liu W. Ubiquitin-proteasome pathway in skeletal muscle atrophy. Front Physiol. 2023;14:1289537.","journal-title":"Front Physiol"},{"key":"2379_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005;15:11\u20138.","journal-title":"Cell Res"},{"key":"2379_CR59","doi-asserted-by":"crossref","unstructured":"Gunadi JW, Welliangan AS, Soetadji RS, Jasaputra DK, Lesmana R. The role of autophagy modulated by exercise in Cancer cachexia. Life (Basel) 11 (2021).","DOI":"10.3390\/life11080781"},{"key":"2379_CR60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41467-023-36817-1","volume":"14","author":"JP Leduc-Gaudet","year":"2023","unstructured":"Leduc-Gaudet JP, et al. MYTHO is a novel regulator of skeletal muscle autophagy and integrity. Nat Commun. 2023;14:1199.","journal-title":"Nat Commun"},{"key":"2379_CR61","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.biocel.2005.03.010","volume":"37","author":"P Costelli","year":"2005","unstructured":"Costelli P, et al. Ca2+-dependent proteolysis in muscle wasting. Int J Biochem Cell Biol. 2005;37:2134\u201346.","journal-title":"Int J Biochem Cell Biol"},{"key":"2379_CR62","doi-asserted-by":"crossref","unstructured":"Yoshida T, Delafontaine P. Mechanisms of IGF-1-Mediated regulation of skeletal muscle hypertrophy and atrophy. Cells 9 (2020).","DOI":"10.3390\/cells9091970"},{"key":"2379_CR63","doi-asserted-by":"crossref","unstructured":"Mart\u00edn AI et al. IGF-1 and IGFBP-3 in inflammatory Cachexia. Int J Mol Sci 22 (2021).","DOI":"10.3390\/ijms22179469"},{"key":"2379_CR64","doi-asserted-by":"publisher","first-page":"785712","DOI":"10.3389\/fcell.2021.785712","volume":"9","author":"MM Chen","year":"2021","unstructured":"Chen MM, Zhao YP, Zhao Y, Deng SL, Yu K. Regulation of myostatin on the growth and development of skeletal muscle. Front Cell Dev Biol. 2021;9:785712.","journal-title":"Front Cell Dev Biol"},{"key":"2379_CR65","doi-asserted-by":"publisher","first-page":"189208","DOI":"10.1016\/j.bbcan.2024.189208","volume":"1879","author":"L Li","year":"2024","unstructured":"Li L, Ling ZQ. Mechanisms of cancer cachexia and targeted therapeutic strategies. Biochim Biophys Acta Rev Cancer. 2024;1879:189208.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2379_CR66","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/jcsm.12449","volume":"10","author":"R Costa","year":"2019","unstructured":"Costa R, et al. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa. J Cachexia Sarcopenia Muscle. 2019;10:1116\u201327.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR67","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.mam.2024.101293","volume":"99","author":"E Tamayo-Torres","year":"2024","unstructured":"Tamayo-Torres E, Garrido A, de Cabo R, Carretero J, G\u00f3mez-Cabrera MC. Molecular mechanisms of cancer cachexia. Role of exercise training. Mol Aspects Med. 2024;99:101293.","journal-title":"Mol Aspects Med"},{"key":"2379_CR68","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","volume":"3","author":"JK Sethi","year":"2021","unstructured":"Sethi JK, Hotamisligil GS. Metabolic messengers: tumour necrosis factor. Nat Metab. 2021;3:1302\u201312.","journal-title":"Nat Metab"},{"key":"2379_CR69","doi-asserted-by":"publisher","first-page":"114137","DOI":"10.1016\/j.addr.2022.114137","volume":"183","author":"M Hu","year":"2022","unstructured":"Hu M, Huang L. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Adv Drug Deliv Rev. 2022;183:114137.","journal-title":"Adv Drug Deliv Rev"},{"key":"2379_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of Cancer-Associated fibroblasts. Physiol Rev. 2021;101:147\u201376.","journal-title":"Physiol Rev"},{"key":"2379_CR71","doi-asserted-by":"crossref","unstructured":"Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. 123, 1902\u201310 (2013).","DOI":"10.1172\/JCI66369"},{"key":"2379_CR72","doi-asserted-by":"crossref","unstructured":"Apte MV et al. Pancreatic stellate cells are activated by Proinflammatory cytokines: implications for pancreatic fibrogenesis. 44, 534\u201341 (1999).","DOI":"10.1136\/gut.44.4.534"},{"key":"2379_CR73","doi-asserted-by":"crossref","unstructured":"Bachem MG et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. 115, 421\u2013\u200932 (1998).","DOI":"10.1016\/S0016-5085(98)70209-4"},{"key":"2379_CR74","doi-asserted-by":"crossref","unstructured":"Friedman G et al. Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4(+) and PDPN(+) CAFs to clinical outcome. 1, 692\u2013708 (2020).","DOI":"10.1038\/s43018-020-0082-y"},{"key":"2379_CR75","doi-asserted-by":"crossref","unstructured":"Raz Y et al. Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer. 215, 3075\u201393 (2018).","DOI":"10.1084\/jem.20180818"},{"key":"2379_CR76","doi-asserted-by":"crossref","unstructured":"Mishra PJ et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. 68, 4331\u20139 (2008).","DOI":"10.1158\/0008-5472.CAN-08-0943"},{"key":"2379_CR77","doi-asserted-by":"crossref","unstructured":"Karnoub AE et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. 449, 557\u2013\u200963 (2007).","DOI":"10.1038\/nature06188"},{"key":"2379_CR78","doi-asserted-by":"crossref","unstructured":"Bochet L et al. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. 73, 5657\u201368 (2013).","DOI":"10.1158\/0008-5472.CAN-13-0530"},{"key":"2379_CR79","doi-asserted-by":"crossref","unstructured":"Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. 315, 1650\u20139 (1986).","DOI":"10.1056\/NEJM198612253152606"},{"key":"2379_CR80","doi-asserted-by":"crossref","unstructured":"Cox TR, Erler JT. Fibrosis and cancer: partners in crime or opposing forces?? 2, 279\u201382 (2016).","DOI":"10.1016\/j.trecan.2016.05.004"},{"key":"2379_CR81","doi-asserted-by":"crossref","unstructured":"Sch Fer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. 9, 628\u2013\u200938 (2008).","DOI":"10.1038\/nrm2455"},{"key":"2379_CR82","doi-asserted-by":"crossref","unstructured":"Lazard D et al. Expression of smooth muscle-specific proteins in Myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. 90, 999\u20131003 (1993).","DOI":"10.1073\/pnas.90.3.999"},{"key":"2379_CR83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast Cancer. Cancer Cell. 2018;33:463\u2013e47910.","journal-title":"Cancer Cell"},{"key":"2379_CR84","doi-asserted-by":"crossref","unstructured":"Zhou Y et al. Single-Cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal Cancer. 38, 818\u2013e8285 (2020).","DOI":"10.1016\/j.ccell.2020.09.015"},{"key":"2379_CR85","doi-asserted-by":"crossref","unstructured":"Biffi G et al. IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. 9, 282\u2013301 (2019).","DOI":"10.1158\/2159-8290.CD-18-0710"},{"key":"2379_CR86","doi-asserted-by":"crossref","unstructured":"Bartoschek M et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. 9, 5150 (2018).","DOI":"10.1038\/s41467-018-07582-3"},{"key":"2379_CR87","doi-asserted-by":"crossref","unstructured":"Bernard V et al. Single-Cell transcriptomics of pancreatic Cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. 25, 2194\u2013205 (2019).","DOI":"10.1158\/1078-0432.CCR-18-1955"},{"key":"2379_CR88","doi-asserted-by":"crossref","unstructured":"Chen Y et al. Type I collagen deletion in \u03b1SMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. 39, 548\u2013e5656 (2021).","DOI":"10.1016\/j.ccell.2021.02.007"},{"key":"2379_CR89","unstructured":"Wu SZ et al. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. 39, e104063 (2020)."},{"key":"2379_CR90","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41568-023-00549-7","volume":"23","author":"M Tsoumakidou","year":"2023","unstructured":"Tsoumakidou M. The advent of immune stimulating CAFs in cancer. Nat Rev Cancer. 2023;23:258\u201369.","journal-title":"Nat Rev Cancer"},{"key":"2379_CR91","doi-asserted-by":"crossref","unstructured":"Peng J et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. 29, 725\u201338 (2019).","DOI":"10.1038\/s41422-019-0195-y"},{"key":"2379_CR92","doi-asserted-by":"crossref","unstructured":"Elyada E et al. Cross-Species Single-Cell analysis of pancreatic ductal adenocarcinoma reveals Antigen-Presenting Cancer-Associated fibroblasts. 9, 1102\u201323 (2019).","DOI":"10.1158\/2159-8290.CD-19-0094"},{"key":"2379_CR93","doi-asserted-by":"crossref","unstructured":"Hosein AN et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. 5 (2019).","DOI":"10.1101\/539874"},{"key":"2379_CR94","doi-asserted-by":"crossref","unstructured":"Li H et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. 49, 708\u201318 (2017).","DOI":"10.1038\/ng.3818"},{"key":"2379_CR95","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214:579\u201396.","journal-title":"J Exp Med"},{"key":"2379_CR96","first-page":"107628","volume":"31","author":"S Davidson","year":"2020","unstructured":"Davidson S, et al. Single-Cell RNA sequencing reveals a dynamic stromal niche that. Supports Tumor Growth. 2020;31:107628.","journal-title":"Supports Tumor Growth"},{"key":"2379_CR97","doi-asserted-by":"crossref","unstructured":"Lambrechts D et al. Phenotype molding of stromal cells in the lung tumor microenvironment. 24, 1277\u201389 (2018).","DOI":"10.1038\/s41591-018-0096-5"},{"key":"2379_CR98","doi-asserted-by":"crossref","unstructured":"Puram SV et al. Single-Cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck Cancer. 171, 1611\u2013e162424 (2017).","DOI":"10.1016\/j.cell.2017.10.044"},{"key":"2379_CR99","doi-asserted-by":"publisher","first-page":"108945","DOI":"10.1016\/j.celrep.2021.108945","volume":"35","author":"F Vald\u00e9s-Mora","year":"2021","unstructured":"Vald\u00e9s-Mora F, et al. Single-cell transcriptomics reveals Involution mimicry during the specification of the basal breast cancer subtype. Cell Rep. 2021;35:108945.","journal-title":"Cell Rep"},{"key":"2379_CR100","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719\u201334.","journal-title":"Cancer Cell"},{"key":"2379_CR101","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1084\/jem.20122344","volume":"210","author":"EW Roberts","year":"2013","unstructured":"Roberts EW, et al. Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med. 2013;210:1137\u201351.","journal-title":"J Exp Med"},{"key":"2379_CR102","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12885-017-3178-8","volume":"17","author":"MJ Alves","year":"2017","unstructured":"Alves MJ, et al. Adipose tissue fibrosis in human cancer cachexia: the role of TGF\u03b2 pathway. BMC Cancer. 2017;17:190.","journal-title":"BMC Cancer"},{"key":"2379_CR103","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/jcsm.12441","volume":"10","author":"J Lima","year":"2019","unstructured":"Lima J, et al. Tumour-derived transforming growth factor-\u03b2 signalling contributes to fibrosis in patients with cancer cachexia. J Cachexia Sarcopenia Muscle. 2019;10:1045\u201359.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR104","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-020-01667-y","volume":"39","author":"R Lappano","year":"2020","unstructured":"Lappano R, et al. The IL1\u03b2-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs). J Exp Clin Cancer Res. 2020;39:153.","journal-title":"J Exp Clin Cancer Res"},{"key":"2379_CR105","doi-asserted-by":"publisher","first-page":"6006","DOI":"10.1158\/1078-0432.CCR-13-1130","volume":"19","author":"S Torres","year":"2013","unstructured":"Torres S, et al. Proteome profiling of cancer-associated fibroblasts identifies novel Proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res. 2013;19:6006\u201319.","journal-title":"Clin Cancer Res"},{"key":"2379_CR106","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2022.09.004","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee JH, Massagu\u00e9 J. TGF-\u03b2 in developmental and fibrogenic EMTs. Semin Cancer Biol. 2022;86:136\u201345.","journal-title":"Semin Cancer Biol"},{"key":"2379_CR107","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/HEP.0000000000000319","volume":"78","author":"Y Song","year":"2023","unstructured":"Song Y, et al. Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-\u03b2\/SMAD signaling. Hepatology. 2023;78:1433\u201347.","journal-title":"Hepatology"},{"key":"2379_CR108","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1681\/ASN.2015050499","volume":"27","author":"SG Szeto","year":"2016","unstructured":"Szeto SG, et al. YAP\/TAZ are mechanoregulators of TGF-\u03b2-Smad signaling and renal fibrogenesis. J Am Soc Nephrol. 2016;27:3117\u201328.","journal-title":"J Am Soc Nephrol"},{"key":"2379_CR109","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jcsm.13199","volume":"14","author":"H Xie","year":"2023","unstructured":"Xie H, et al. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2023;14:869\u201378.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR110","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jcsm.12357","volume":"10","author":"RD Dolan","year":"2019","unstructured":"Dolan RD, et al. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J Cachexia Sarcopenia Muscle. 2019;10:111\u201322.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR111","doi-asserted-by":"publisher","first-page":"188761","DOI":"10.1016\/j.bbcan.2022.188761","volume":"1877","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu M, Wu X, Zhang Y, Xia Y. Muscle-to-tumor crosstalk: the effect of exercise-induced myokine on cancer progression. Biochim Biophys Acta Rev Cancer. 2022;1877:188761.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2379_CR112","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jshs.2018.08.002","volume":"8","author":"D Yeo","year":"2019","unstructured":"Yeo D, Kang C, Zhang T, Ji LL. Avenanthramides attenuate inflammation and atrophy in muscle cells. J Sport Health Sci. 2019;8:189\u201395.","journal-title":"J Sport Health Sci"},{"key":"2379_CR113","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2865","volume":"15","author":"J Mauer","year":"2014","unstructured":"Mauer J, et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014;15:423\u201330.","journal-title":"Nat Immunol"},{"key":"2379_CR114","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1073\/pnas.1920004117","volume":"117","author":"MS Han","year":"2020","unstructured":"Han MS, et al. Regulation of adipose tissue inflammation by Interleukin 6. Proc Natl Acad Sci U S A. 2020;117:2751\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2379_CR115","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1038\/onc.2014.286","volume":"34","author":"V De Simone","year":"2015","unstructured":"De Simone V, et al. Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015;34:3493\u2013503.","journal-title":"Oncogene"},{"key":"2379_CR116","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s42255-022-00538-4","volume":"4","author":"TM Kistner","year":"2022","unstructured":"Kistner TM, Pedersen BK, Lieberman DE. Interleukin 6 as an energy allocator in muscle tissue. Nat Metab. 2022;4:170\u20139.","journal-title":"Nat Metab"},{"key":"2379_CR117","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jcsm.13109","volume":"14","author":"I Pototschnig","year":"2023","unstructured":"Pototschnig I, et al. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL\/6 model of cancer-associated cachexia. J Cachexia Sarcopenia Muscle. 2023;14:93\u2013107.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2379_CR118","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1186\/s12885-018-5080-4","volume":"18","author":"SM Advani","year":"2018","unstructured":"Advani SM, Advani PG, VonVille HM, Jafri SH. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials. BMC Cancer. 2018;18:1174.","journal-title":"BMC Cancer"},{"key":"2379_CR119","doi-asserted-by":"publisher","first-page":"114587","DOI":"10.1016\/j.celrep.2024.114587","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution. Cell Rep. 2024;43:114587.","journal-title":"Cell Rep"},{"key":"2379_CR120","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","volume":"41","author":"H Wang","year":"2023","unstructured":"Wang H, et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell. 2023;41:1345\u2013e13629.","journal-title":"Cancer Cell"},{"key":"2379_CR121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","volume":"25","author":"UE Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol. 2014;25:47\u201360.","journal-title":"Semin Cancer Biol"},{"key":"2379_CR122","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun C, Qin Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics. 2021;11:8322\u201336.","journal-title":"Theranostics"},{"key":"2379_CR123","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","volume":"1870","author":"L Sun","year":"2018","unstructured":"Sun L, Suo C, Li ST, Zhang H, Gao P. Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect. Biochim Biophys Acta Rev Cancer. 2018;1870:51\u201366.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2379_CR124","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-17-2928","volume":"78","author":"W Zhang","year":"2018","unstructured":"Zhang W, et al. GFPT2-Expressing Cancer-Associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Res. 2018;78:3445\u201357.","journal-title":"Cancer Res"},{"key":"2379_CR125","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-017-0448-5","volume":"10","author":"D von Ahrens","year":"2017","unstructured":"von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 2017;10:76.","journal-title":"J Hematol Oncol"},{"key":"2379_CR126","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, et al. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18:70.","journal-title":"Mol Cancer"},{"key":"2379_CR127","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","volume":"99","author":"G Ishii","year":"2016","unstructured":"Ishii G, Ochiai A, Neri S. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv Drug Deliv Rev. 2016;99:186\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"2379_CR128","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18:99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"key":"2379_CR129","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canlet.2015.10.027","volume":"380","author":"P Chiarugi","year":"2016","unstructured":"Chiarugi P, Cirri P. Metabolic exchanges within tumor microenvironment. Cancer Lett. 2016;380:272\u201380.","journal-title":"Cancer Lett"},{"key":"2379_CR130","doi-asserted-by":"publisher","first-page":"e11466","DOI":"10.15252\/emmm.201911466","volume":"12","author":"M Cangkrama","year":"2020","unstructured":"Cangkrama M, et al. A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming. EMBO Mol Med. 2020;12:e11466.","journal-title":"EMBO Mol Med"},{"key":"2379_CR131","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41420-025-02420-0","volume":"11","author":"Z Ma","year":"2025","unstructured":"Ma Z, et al. CXCL12 alone is enough to reprogram normal fibroblasts into Cancer-Associated fibroblasts. Cell Death Discov. 2025;11:156.","journal-title":"Cell Death Discov"},{"key":"2379_CR132","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.molcel.2023.06.010","volume":"83","author":"Y Su","year":"2023","unstructured":"Su Y, et al. Glucose-induced CRL4(COP1)-p53 axis amplifies glycometabolism to drive tumorigenesis. Mol Cell. 2023;83:2316\u2013e23317.","journal-title":"Mol Cell"},{"key":"2379_CR133","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s42255-024-01011-0","volume":"6","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Activation of GPR81 by lactate drives tumour-induced cachexia. Nat Metab. 2024;6:708\u201323.","journal-title":"Nat Metab"},{"key":"2379_CR134","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3389\/fimmu.2018.01125","volume":"9","author":"EJ Beswick","year":"2018","unstructured":"Beswick EJ, et al. Expression of programmed Death-Ligand 1 by human colonic CD90(+) stromal cells differs between ulcerative colitis and crohn\u2019s disease and determines their capacity to suppress Th1 cells. Front Immunol. 2018;9:1125.","journal-title":"Front Immunol"},{"key":"2379_CR135","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/s41388-019-1141-7","volume":"39","author":"G Brummer","year":"2020","unstructured":"Brummer G, et al. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. Oncogene. 2020;39:2275\u201389.","journal-title":"Oncogene"},{"key":"2379_CR136","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka K, et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. 2021;184:4734\u2013e475220.","journal-title":"Cell"},{"key":"2379_CR137","doi-asserted-by":"crossref","unstructured":"Rupert JE et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J Exp Med 218 (2021).","DOI":"10.1084\/jem.20190450"},{"key":"2379_CR138","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12935-022-02599-7","volume":"22","author":"B Feng","year":"2022","unstructured":"Feng B, Wu J, Shen B, Jiang F, Feng J. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell Int. 2022;22:166.","journal-title":"Cancer Cell Int"},{"key":"2379_CR139","doi-asserted-by":"publisher","first-page":"P19","DOI":"10.1186\/2049-3002-2-S1-P19","volume":"2","author":"JM Garcia","year":"2014","unstructured":"Garcia JM, Yan Y, Manning-Duus E, Friend J. Effects of the Ghrelin receptor agonist Anamorelin on lean body mass in cancer patients with cachexia; results from a phase II randomized, double blind, multicenter study. Cancer Metabolism. 2014;2:P19.","journal-title":"Cancer Metabolism"},{"key":"2379_CR140","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","volume":"391","author":"JD Groarke","year":"2024","unstructured":"Groarke JD, et al. Ponsegromab for the treatment of Cancer cachexia. N Engl J Med. 2024;391:2291\u2013303.","journal-title":"N Engl J Med"},{"key":"2379_CR141","doi-asserted-by":"publisher","first-page":"C908","DOI":"10.1152\/ajpcell.00677.2024","volume":"328","author":"OF Bathe","year":"2025","unstructured":"Bathe OF. Tumor metabolism as a factor affecting diversity in cancer cachexia. Am J Physiol Cell Physiol. 2025;328:C908\u201320.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2379_CR142","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/ijc.26174","volume":"129","author":"TH Chung","year":"2011","unstructured":"Chung TH, Yen-Ping KM, Chen JK, Huang DM. YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis. Int J Cancer. 2011;129:2274\u201383.","journal-title":"Int J Cancer"},{"key":"2379_CR143","doi-asserted-by":"publisher","first-page":"e2207010","DOI":"10.1002\/advs.202207010","volume":"10","author":"SY Yu","year":"2023","unstructured":"Yu SY, et al. Uncovering Tumor-Promoting roles of activin A in pancreatic ductal adenocarcinoma. Adv Sci (Weinh). 2023;10:e2207010.","journal-title":"Adv Sci (Weinh)"},{"key":"2379_CR144","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-024-00523-y","volume":"8","author":"Y Hu","year":"2024","unstructured":"Hu Y, et al. INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer. NPJ Precis Oncol. 2024;8:35.","journal-title":"NPJ Precis Oncol"},{"key":"2379_CR145","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/cdd.2014.98","volume":"21","author":"L Gangoda","year":"2014","unstructured":"Gangoda L, et al. Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice. Cell Death Differ. 2014;21:1815\u201324.","journal-title":"Cell Death Differ"},{"key":"2379_CR146","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1158\/0008-5472.CAN-08-1343","volume":"68","author":"J Laurencikiene","year":"2008","unstructured":"Laurencikiene J, et al. Evidence for an important role of CIDEA in human cancer cachexia. Cancer Res. 2008;68:9247\u201354.","journal-title":"Cancer Res"},{"key":"2379_CR147","doi-asserted-by":"publisher","first-page":"114972","DOI":"10.1016\/j.celrep.2024.114972","volume":"43","author":"X Han","year":"2024","unstructured":"Han X, et al. Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment. Cell Rep. 2024;43:114972.","journal-title":"Cell Rep"},{"key":"2379_CR148","doi-asserted-by":"publisher","first-page":"189103","DOI":"10.1016\/j.bbcan.2024.189103","volume":"1879","author":"I Mota","year":"2024","unstructured":"Mota I, Satari S, Marques IS, Santos J, Medeiros R. Adipose tissue rearrangement in cancer cachexia: the involvement of \u03b23-adrenergic receptor associated pathways. Biochim Biophys Acta Rev Cancer. 2024;1879:189103.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2379_CR149","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.addr.2017.07.010","volume":"121","author":"S Yazdani","year":"2017","unstructured":"Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: implications for fibrosis and cancer. Adv Drug Deliv Rev. 2017;121:101\u201316.","journal-title":"Adv Drug Deliv Rev"},{"key":"2379_CR150","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20130110","volume":"210","author":"E Tran","year":"2013","unstructured":"Tran E, et al. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. J Exp Med. 2013;210:1125\u201335.","journal-title":"J Exp Med"},{"key":"2379_CR151","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E. In search of definitions: Cancer-associated fibroblasts and their markers. Int J Cancer. 2020;146:895\u2013905.","journal-title":"Int J Cancer"},{"key":"2379_CR152","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ng.3818","volume":"49","author":"H Li","year":"2017","unstructured":"Li H, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet. 2017;49:708\u201318.","journal-title":"Nat Genet"},{"key":"2379_CR153","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1039\/C5FO00478K","volume":"6","author":"L Du","year":"2015","unstructured":"Du L, et al. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly via inhibiting lipolysis. Food Funct. 2015;6:3652\u201362.","journal-title":"Food Funct"},{"key":"2379_CR154","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","volume":"52","author":"KC Fearon","year":"2003","unstructured":"Fearon KC, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52:1479\u201386.","journal-title":"Gut"},{"key":"2379_CR155","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/apm.2018.07.06","volume":"8","author":"BL Prado","year":"2019","unstructured":"Prado BL, Qian Y. Anti-cytokines in the treatment of cancer cachexia. Ann Palliat Med. 2019;8:67\u201379.","journal-title":"Ann Palliat Med"},{"key":"2379_CR156","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","volume":"31","author":"FE Del","year":"2013","unstructured":"Del FE, Dev R, Hui D, Palmer L, Bruera E. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol. 2013;31:1271\u20136.","journal-title":"J Clin Oncol"},{"key":"2379_CR157","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jpainsymman.2011.03.007","volume":"43","author":"M Davis","year":"2012","unstructured":"Davis M, et al. A phase II dose Titration study of thalidomide for cancer-associated anorexia. J Pain Symptom Manage. 2012;43:78\u201386.","journal-title":"J Pain Symptom Manage"},{"key":"2379_CR158","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/s41467-023-37595-6","volume":"14","author":"M Beltra","year":"2023","unstructured":"Beltra M, et al. NAD(+) repletion with niacin counteracts cancer cachexia. Nat Commun. 2023;14:1849.","journal-title":"Nat Commun"},{"key":"2379_CR159","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/01635581.2011.563032","volume":"63","author":"S Shadfar","year":"2011","unstructured":"Shadfar S, et al. Oral Resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer. 2011;63:749\u201362.","journal-title":"Nutr Cancer"},{"key":"2379_CR160","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/CS20030301","volume":"106","author":"MD Barber","year":"2004","unstructured":"Barber MD, et al. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. Clin Sci (1979). 2004;106:359.","journal-title":"Clin Sci (1979)"},{"key":"2379_CR161","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1080\/15548627.2023.2300913","volume":"20","author":"X Zhang","year":"2024","unstructured":"Zhang X, et al. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024;20:1314\u201334.","journal-title":"Autophagy"},{"key":"2379_CR162","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, et al. IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9:282\u2013301.","journal-title":"Cancer Discov"},{"key":"2379_CR163","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21:144.","journal-title":"Mol Cancer"},{"key":"2379_CR164","doi-asserted-by":"crossref","unstructured":"Li C et al. FGF19-Induced inflammatory CAF promoted neutrophil extracellular trap formation in the liver metastasis of colorectal Cancer. Adv Sci 10 (2023).","DOI":"10.1002\/advs.202302613"},{"key":"2379_CR165","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther. 2021;6:218.","journal-title":"Signal Transduct Target Ther"},{"key":"2379_CR166","first-page":"295","volume":"26","author":"T Zhang","year":"2024","unstructured":"Zhang T, et al. Integrating single-cell and Spatial transcriptomics reveals Endoplasmic reticulum stress-related CAF subpopulations associated with Chordoma progression. Neurooncology. 2024;26:295\u2013308.","journal-title":"Neurooncology"},{"key":"2379_CR167","doi-asserted-by":"publisher","first-page":"e113898","DOI":"10.15252\/embj.2023113898","volume":"42","author":"A Hess","year":"2023","unstructured":"Hess A, et al. Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. EMBO J. 2023;42:e113898.","journal-title":"EMBO J"},{"key":"2379_CR168","doi-asserted-by":"crossref","unstructured":"Shaashua L et al. BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling. Nat Commun 13 (2022).","DOI":"10.1038\/s41467-022-34081-3"},{"key":"2379_CR169","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2023.12.011","volume":"187","author":"Y Shapir Itai","year":"2024","unstructured":"Shapir Itai Y, et al. Bispecific dendritic-T cell engager potentiates anti-tumor immunity. Cell. 2024;187:375\u2013e38918.","journal-title":"Cell"},{"key":"2379_CR170","doi-asserted-by":"crossref","unstructured":"Zhang L et al. Transient intracellular expression of PD-L1 and VEGFR2 bispecific nanobody in cancer cells inspires long-term T cell activation and infiltration to combat tumor and inhibit cancer metastasis. Mol Cancer 24 (2025).","DOI":"10.1186\/s12943-025-02253-6"},{"key":"2379_CR171","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41551-021-00800-2","volume":"5","author":"L Liu","year":"2021","unstructured":"Liu L, et al. Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells. Nat Biomedical Eng. 2021;5:1261\u201373.","journal-title":"Nat Biomedical Eng"},{"key":"2379_CR172","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol. 2024;17:5.","journal-title":"J Hematol Oncol"},{"key":"2379_CR173","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","volume":"22","author":"F Weiss","year":"2022","unstructured":"Weiss F, Lauffenburger D, Friedl P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nat Rev Cancer. 2022;22:157\u201373.","journal-title":"Nat Rev Cancer"},{"key":"2379_CR174","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2021.02.012","volume":"172","author":"H Liu","year":"2021","unstructured":"Liu H, Shi Y, Qian F. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Adv Drug Deliv Rev. 2021;172:37\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"2379_CR175","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41416-020-01226-4","volume":"124","author":"RV Broad","year":"2021","unstructured":"Broad RV, et al. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy. Br J Cancer. 2021;124:1110\u201320.","journal-title":"Br J Cancer"},{"key":"2379_CR176","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2016.03.001","volume":"45","author":"C Chargari","year":"2016","unstructured":"Chargari C, et al. Optimize and refine therapeutic index in radiation therapy: overview of a century. Cancer Treat Rev. 2016;45:58\u201367.","journal-title":"Cancer Treat Rev"},{"key":"2379_CR177","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/acs.nanolett.6b04150","volume":"17","author":"Z Zhen","year":"2017","unstructured":"Zhen Z, et al. Protein nanocage mediated Fibroblast-Activation protein targeted photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control. Nano Lett. 2017;17:862\u20139.","journal-title":"Nano Lett"},{"key":"2379_CR178","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.trecan.2022.03.001","volume":"8","author":"PE Saw","year":"2022","unstructured":"Saw PE, Chen J, Song E. Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer. 2022;8:527\u201355.","journal-title":"Trends Cancer"}],"updated-by":[{"DOI":"10.1186\/s12943-025-02453-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000}}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02379-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T06:03:26Z","timestamp":1756965806000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02379-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02379-7","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12943-025-02453-0","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Following publication of this article, the author reported that the Figure 2 is repeatedly captured as Figure 4. The incorrect and correct Figure 4 are provided in the erratum 10.1186\/s12943-025-02453-0.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12943-025-02453-0","URL":"https:\/\/doi.org\/10.1186\/s12943-025-02453-0","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}